Company intelligence / Profile preview

Afraceuticals

Mooi River, KwaZulu-Natal, South Africa

Ownership: Private
Development stage: Other

Overview

Afraceuticals' flagship product PELAFORCE™, a Pelargonium sidoides root extract, is commercially available and recognized for antiviral, antibacterial, immune-modulating, and mucolytic effects. PELAFORCE™ is listed in the European and African Pharmacopoeia, and has received a Natural Product Number from Health Canada. No clinical trial data is disclosed, but the extract is recognized and sold as a botanical medicine and dietary supplement.[1][3][6]

Therapeutic areas: Infectious Diseases
Modalities: Botanical extractHerbal medicinePlant-derived product
Industry: Food & Nutrition

Beyond the preview

Go deeper on Afraceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Afraceuticals.

Explore the full profile